Arcus Biosciences, Inc. Quarterly Debt-to-equity in % from Q3 2018 to Q3 2022

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Arcus Biosciences, Inc. quarterly Debt-to-equity history and growth rate from Q3 2018 to Q3 2022.
Arcus Biosciences, Inc. Debt-to-equity for the quarter ending September 30, 2022 was 94.7 %, a 93.7% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2022	94.7	+45.8	+93.7%	Sep 30, 2022
Q2 2022	86.2	+38.6	+81.2%	Jun 30, 2022
Q1 2022	75	+34.8	+86.6%	Mar 31, 2022
Q4 2021	60.7	+22.1	+57%	Dec 31, 2021
Q3 2021	48.9	+18	+58.5%	Sep 30, 2021
Q2 2021	47.6	+29.2	+159%	Jun 30, 2021
Q1 2021	40.2	+17.1	+73.8%	Mar 31, 2021
Q4 2020	38.7	+17.8	+85.5%	Dec 31, 2020
Q3 2020	30.8	+11.7	+61.1%	Sep 30, 2020
Q2 2020	18.4	+0.45	+2.51%	Jun 30, 2020
Q1 2020	23.1	+6.61	+40%	Mar 31, 2020
Q4 2019	20.8	+4.89	+30.7%	Dec 31, 2019
Q3 2019	19.2	-3.38	-15%	Sep 30, 2019
Q2 2019	17.9			Jun 30, 2019
Q1 2019	16.5			Mar 31, 2019
Q4 2018	16			Dec 31, 2018
Q3 2018	22.5			Sep 30, 2018

* An asterisk sign (*) next to the value indicates that the value is likely invalid.